| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BA | Common Stock | Award | $0 | +8,291 | +59% | $0.000000 | 22,371 | 19 Feb 2025 | Direct | F1 |
| transaction | BA | Common Stock | Sale | $570,759 | -3,159 | -14% | $180.69 | 19,213 | 20 Feb 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BA | Stock Option (Right to Buy) | Award | $0 | +23,513 | $0.000000 | 23,513 | 19 Feb 2025 | Common Stock | 23,513 | $221.44 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units of which 2,736 units will vest on February 19, 2026, 2,736 units will vest on February 19, 2027 and 2,819 units will vest on February 22, 2028; units settle in shares of the Company's common stock on a one-for-one basis. |
| F2 | The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $180.690 to $180.705 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The exercise price is equal to 120% of the average of the high and low trading prices on the date of grant. |
| F4 | The option becomes vested and exercisable in full on February 19, 2028, which is the third anniversary of the date of grant. |